We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

90 hedge funds and large institutions have $80.7M invested in VanEck Biotech ETF in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 30 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,239% more call options, than puts

Call options by funds: $6.36M | Put options by funds: $475K

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

20% more capital invested

Capital invested by funds: $67.4M → $80.7M (+$13.3M)

7% more funds holding

Funds holding: 84 → 90 (+6)

1.77% more ownership

Funds ownership: 17.86% → 19.62% (+1.8%)

50% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 30

Holders
90
Holders Change
+6
Holders Change %
+7.14%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
30
Closed
8
Calls
$6.36M
Puts
$475K
Net Calls
+$5.89M
Net Calls Change
+$5.8M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$3.23M
2
Bank of America
Bank of America
North Carolina
+$1.34M
3
Simplex Trading
Simplex Trading
Illinois
+$885K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$621K
5
MJRIC
Mogy Joel R Investment Counsel
California
+$310K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.92M
2
Jane Street
Jane Street
New York
-$1.56M
3
VF
Virtu Financial
New York
-$1.53M
4
SFS
Strategic Financial Services
New York
-$1.37M
5
TRCT
Tower Research Capital (TRC)
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
GJIC
26
Gamble Jones Investment Counsel
California
$771K – – –
ACA
27
Atlas Capital Advisors
Wyoming
$771K – – –
Janney Montgomery Scott
28
Janney Montgomery Scott
Pennsylvania
$770K -$25.3K -200 -3%
PAG
29
Private Advisor Group
New Jersey
$730K -$31.6K -250 -4%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$707K -$37.9K -300 -5%
SBH
31
Segall Bryant & Hamill
Illinois
$699K – – –
IFWM
32
Institute for Wealth Management
Colorado
$655K -$8.84K -70 -1%
TC
33
Telemus Capital
Michigan
$637K – – –
FNBOSM
34
First National Bank of South Miami
Florida
$552K +$24.6K +195 +5%
IAMOG
35
Investors Asset Management of Georgia
Georgia
$475K – – –
SC
36
Scotia Capital
Ontario, Canada
$465K -$4.93K -39 -1%
SB
37
Suntrust Banks
Georgia
$460K +$66.8K +529 +17%
WJA
38
Williams Jones & Associates
New York
$451K -$10.7K -85 -2%
IA
39
IFP Advisors
Florida
$428K +$25.5K +202 +6%
AB
40
Atlas Brown
Kentucky
$362K -$8.34K -66 -2%
FFN
41
Focus Financial Network
Minnesota
$295K +$290K +2,298 New
First Manhattan
42
First Manhattan
New York
$276K – – –
MML Investors Services
43
MML Investors Services
Massachusetts
$275K +$30.7K +243 +13%
TRCT
44
Tower Research Capital (TRC)
New York
$261K -$1.27M -10,073 -83%
PA
45
PFG Advisors
Arizona
$260K -$23.2K -184 -8%
Jane Street
46
Jane Street
New York
$255K -$1.56M -12,371 -86%
MWA
47
MFA Wealth Advisors
Pennsylvania
$231K +$227K +1,800 New
TCM
48
Tufton Capital Management
Maryland
$212K +$208K +1,650 New
CIBC World Market
49
CIBC World Market
Ontario, Canada
$208K +$204K +1,618 New
FANJ
50
Financial Architects (New Jersey)
New Jersey
$202K – – –
1
2
3 4

BBH Hedge Fund Activity: Q1 2019 in Review

90 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2019, worth a combined $80.7M — up 20% from $67.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BBH positions and 8 closed out — a net gain of 6 holders — while 15 added to existing stakes and 30 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $3.23M. The largest seller was Royal Bank of Canada, cutting an estimated $1.92M.

  • 90 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2019, up from 84 in Q4 2018.
  • Funds reported $80.7M of VanEck Biotech ETF stock for Q1 2019, up 20% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q1 2019 and 8 closed out, a net change of +6 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2019 was Citadel Advisors, an estimated $3.23M added.
  • The largest VanEck Biotech ETF seller in Q1 2019 was Royal Bank of Canada, an estimated $1.92M sold.

Based on aggregated 13F filings for Q1 2019.